Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
44
Frequently Asked Questions
What is Market Cap of Kiromic BioPharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Kiromic BioPharma Inc market cap is $3.00.
What is the 52-week high for Kiromic BioPharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiromic BioPharma Inc 52 week high is $1.60 as of February 23, 2026.
What was Kiromic BioPharma Inc stock price yesterday?
Kiromic BioPharma Inc stock price yesterday was $0.0001.
How many employees does Kiromic BioPharma Inc have?